| |
Testimony
- Prepared Statement of the Federal Trade Commission On "How Pay-For-Delay Settlements Make Consumers and the Federal Government Pay More For Much Needed Drugs," Presented By Commissioner J. Thomas Rosch
Before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, United States House of Representatives (March 31, 2009)
- Oral Statement of FTC Commissioner Jon Leibowitz
Hearing of the House Subcommittee on Commerce, Trade, and Consumer Protection
Before the Committee on Energy and Commerce (May 2, 2007)
- Oral Statement of Commissioner J. Thomas Rosch
FTC Oversight Hearing
Before the Committee on Commerce, Science and Transportation, United States Senate (April 10, 2007)
- Prepared Statement of the Federal Trade Commission Concerning the October 2003 Commission Report on Competition and Patent Law and Policy
Presented by Suzanne Michel, Deputy Assistant Director for Policy and Coordination, Bureau of Competition
Before the Subcommittee on Courts, the Internet, and Intellectual Property of the Committee on the Judiciary, United States House of Representatives (February 15, 2007)
- Oral Statement of Commissioner Jon Leibowitz on Anticompetitive Patent Settlements in the Pharmaceutical Industry
Before the Senate Judiciary Committee (January 17, 2007)
- Prepared Statement of the Federal Trade Commission, Barriers to Generic Entry
Presented by Commissioner Jon Leibowitz
Before the Special Committee on Aging, United States Senate. (July 20, 2006)
- FTC Staff Testimony
Before the Antitrust Modernization Commission Concerning Patent Law Reform (November 8, 2005)
- Prepared Statement of the Commission on "Competition In The Pharmaceutical Marketplace: Antitrust Implications of Patent Settlements,"
Presented by Molly Boast, Director, Bureau of Competition,
Before the Committee on the Judiciary, United States Senate. (May 24, 2001)
|
